Apaf-1 is a transcriptional target for E2F and p53
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [90]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Consistent with this role, the pRB pathway is deregulated in most human cancers (reviewed in ref”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 1×
“Increased levels of Apaf-1 as a result of increased E2F activity could provide an explanation for the greater sensitivity of tumour cells to a variety of apoptosis-inducing agents, including chemotherapeutic drug”
BackgroundApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundThe coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 1×
“This suggestion was further substantiated by results—published while this manuscript was undergoing review—showing that Apaf-1 expression is lost in a number of malignant melanomas owing to a combination of allelic loss and transcriptional silencin”
Resultp73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Cited by
Items 201–300 of 707
p53: 25 years of research and more questions to answer
Bourdon, J., Laurenzi, V. D., Melino, G., & Lane, D. P. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401243 · Cited by 76
E2F1: a promising regulator in ovarian carcinoma
Zhan, L., Zhang, Y., Wang, W., Song, E., Fan, Y., & Wei, B. (2016) · Tumor Biology · doi:10.1007/s13277-015-4770-7 · Cited by 76
Tucka, J., Yu, H., Gray, K., Figg, N. L., Maguire, J. J., Lam, B., Bennett, M. R., & Littlewood, T. D. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304284 · Cited by 75
de Oliveira, A. R., Beyer, G., Chugh, R., Skube, S. J., Majumder, K., Banerjee, S., Sangwan, V., Li, L., Dawra, R. K., Subramanian, S., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.46 · Cited by 75
The Chemokine Receptor CXCR4 Regulates Cell-Cycle Proteins in Neurons
Khan, M. Z., Brandimarti, R., Musser, B. J., Resue, D. M., Fatatis, A., & Meucci, O. (2003) · Journal of NeuroVirology · doi:10.1080/13550280390201010 · Cited by 75
“…factor E2F-1, which activates expression of apoptotic genes (i.e., Apaf-1, p53, and Bax) as well as genes required for entry into S phase, and down-regulates the activation of antiapoptotic signals (i.e., nuclear factor [NF]κB) (Phillips et al, 1999; Harbour and Dean, 2000b; Moroni et al, 2001).”
BackgroundGomyo, Y., Sasaki, J.-I., Branch, C. D., Roth, J. A., & Mukhopadhyay, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207381 · Cited by 74
Manickavinayaham, S., Vélez-Cruz, R., Biswas, A., Bedford, E., Klein, B. J., Kutateladze, T. G., Liu, B., Bedford, M. T., & Johnson, D. G. (2019) · Nature Communications · doi:10.1038/s41467-019-12861-8 · Cited by 74
Tyagi, S., & Herr, W. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.258 · Cited by 75
“In contrast, E2F1 is well known to support an apoptotic DDR, through p53-dependent and p53-independent pathways (Bates et al, 1998; Irwin et al, 2000; Stiewe and Pützer, 2000; Moroni et al, 2001; Powers et al, 2004; Radhakrishnan et al, 2004; Rogoff et al, 2004; Frame et al, 2006).”
BackgroundRanganathan, S., & Bowser, R. (2010) · The Open Pathology Journal · doi:10.2174/1874375701004010011 · Cited by 67
“Expression and subcellular distribution of p53, retinoblastoma, Bax, Fas, and caspases were explored by immunoblot, immunohistochemistry and double-label confocal microscopy in the spinal cord and motor cortex of ALS and control subjects.”
BackgroundMacleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 74
Chemotherapy response and resistance
Lee, S., & Schmitt, C. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00014-x · Cited by 73
Rozenfeld-Granot, G., Krishnamurthy, J., Kannan, K., Toren, A., Amariglio, N., Givol, D., & Rechavi, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205218 · Cited by 72
“While this work was in preparation Moroni et al. (2001) demonstrated that Apaf-1 promoter is indeed a target for p53 activation.”
BackgroundMethodSin3a is essential for the genome integrity and viability of pluripotent cells
McDonel, P., Demmers, J., Tan, D. W. M., Watt, F., & Hendrich, B. D. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2011.12.019 · Cited by 66
“5 ICM cells deleted for Sin3a were destined for apoptosis, they did not show induction of the p53 targets p21 (cell cycle arrest), Apaf-1 [apoptosis, (Moroni et al., 2001)], or Dram [autophagy and apoptosis, (Crighton et al., 2006)] (Fig.”
BackgroundDisson, O., Haouzi, D., Desagher, S., Loesch, K., Hahne, M., Kremer, E. J., Jacquet, C., Lemon, S. M., Hibner, U., & Lerat, H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.005 · Cited by 72
E2F1 death pathways as targets for cancer therapy
Pützer, B. M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00030.x · Cited by 72
“Apoptotic targets of E2F1 in the absence of p53 include the p53 homolog protein p73 [40, 41] and apoptosis protease-activating factor 1 (Apaf1) [42] both of which are transcriptionally regulated by E2F1.”
BackgroundBoesten, L. S. M., Zadelaar, S. M., De Clercq, S., Francoz, S., van Nieuwkoop, A., Biessen, E. A. L., Hofmann, F., Feil, S., Feil, R., Jochemsen, A. G., et al. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401973 · Cited by 70
Johnson, C. E., Huang, Y. Y., Parrish, A. B., Smith, M. I., Vaughn, A. E., Zhang, Q., Wright, K. M., Van Dyke, T., Wechsler-Reya, R. J., Kornbluth, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709101105 · Cited by 69
Hu, S., Zhou, M., Jiang, J., Wang, J., Elashoff, D. A., Gorr, S., Michie, S. A., Spijkervet, F. K. L., Bootsma, H., Kallenberg, C. G. M., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24150 · Cited by 69
Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis
Sadasivam, S., Gupta, S., Radha, V., Batta, K., Kundu, T. K., & Swarup, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208201 · Cited by 69
E2F1 Modulates p38 MAPK Phosphorylation via Transcriptional Regulation of ASK1 and Wip1
Hershko, T., Korotayev, K., Polager, S., & Ginsberg, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601758200 · Cited by 69
NEDDylation controls the target specificity of E2F1 and apoptosis induction
Aoki, I., Higuchi, M., & Gotoh, Y. (2012) · Oncogene · doi:10.1038/onc.2012.428 · Cited by 67
Physiological and pathological roles of Apaf1 and the apoptosome
Ferraro, E., Corvaro, M., & Cecconi, F. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00199.x · Cited by 60
“Since E2F could also induce p53, it was also showed in p53 null contest, that Apaf1 activation by p53 or by E2F are two independent processes [35].”
BackgroundSelf-citationDistinct Pathways Mediate UV-Induced Apoptosis in Drosophila Embryos
Zhou, L. J., & Steller, H. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00085-6 · Cited by 67
“( Moroni et al., 2001).”
Ajay, A. K., Upadhyay, A. K., Singh, S., Vijayakumar, M. V., Kumari, R., V, Pandey, V., Boppana, R., & Bhat, M. K. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-204 · Cited by 66
“p53 executes its apoptotic function through intrinsic or extrinsic pathways [42,43].”
BackgroundRegulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation
Berton, T. R., Mitchell, D. L., Guo, R. R., & Johnson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208462 · Cited by 66
ASPP1 and ASPP2 are new transcriptional targets of E2F
Fogal, V., Kartasheva, N. N., Trigiante, G., Llanos, S., Yap, D., Vousden, K. H., & Lü, X. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401562 · Cited by 65
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
Chen, D., Padiernos, E., Ding, F., Lossos, I. S., & Lopez, C. D. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401536 · Cited by 65
Tan, J., Zhuang, L., Jiang, X., Yang, K. K., Karuturi, K. M., & Yu, Q. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512719200 · Cited by 64
NPAT Expression Is Regulated by E2F and Is Essential for Cell Cycle Progression
Gao, G., Bracken, A. P., Burkard, K. T. D., Pasini, D., Classon, M., Attwooll, C. L., Sagara, M., Imai, T., Helin, K., & Zhao, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2821-2833.2003 · Cited by 65
“As previously reported (26, 49), we found that the ER-E2F1 protein was localized in the cytoplasm in the absence of OHT and entered the nucleus rapidly when cells were treated with OHT (data not shown).”
Self-citationMatrix Metalloproteinases 9 and 10 Inhibit Protein Kinase C–Potentiated, p53-Mediated Apoptosis
Meyer, É., Vollmer, J.-Y., Bovey, R., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2908 · Cited by 65
The Bcl-2 protein family and its role in the development of neoplastic disease
Heiser, D., Labi, V., Erlacher, M., & Villunger, A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.011 · Cited by 66
Emanuele, S., D’Anneo, A., Bellavia, G., Vassallo, B., Lauricella, M., Blasio, A. D., Vento, R., & Tesoriere, G. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.039 · Cited by 64
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression
Zhou, Y., Nakajima, R., Shirasawa, M., Fikriyanti, M., Zhao, L., Iwanaga, R., Bradford, A. P., Kurayoshi, K., Araki, K., & Ohtani, K. (2023) · Biology · doi:10.3390/biology12121511 · Cited by 65
The role of the transcription factor DP in apoptosis
Hitchens, M. R., & Robbins, P. D. (2003) · APOPTOSIS · doi:10.1023/a:1025586207239 · Cited by 64
Splicing DNA-damage responses to tumour cell death
Crighton, D., & Ryan, K. M. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.001 · Cited by 63
Gene Set Expression Comparison kit for BRB-ArrayTools
Xu, X., Zhao, Y., & Simon, R. M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm541 · Cited by 63
“For example, E2F-1 interacts with p53 to regulate transcription of some genes including Apaf-1 (Moroni et al., 2001).”
BackgroundNeuronal Survival and p73/p63/p53: A Family Affair
Jacobs, W. B., Walsh, G. S., & Miller, F. D. (2004) · The Neuroscientist · doi:10.1177/1073858404263456 · Cited by 63
Joshi, B., Ko, D., Ordonez‐Ercan, D., & Chellappan, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.148 · Cited by 63
Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours
di Pietro, A., de Vries, E. G. E., Gietema, J. A., Spierings, D. C. J., & de Jong, S. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.06.014 · Cited by 64
Tashiro, E., Maruki, H., Minato, Y., Doki, Y., Weinstein, I. B., & Imoto, M. (2003) · PubMed · Cited by 62
Deng, W., Kawashima, H., Wu, G., Jayachandran, G., Xu, K., Minna, J. D., Roth, J. A., & Ji, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3463 · Cited by 61
“Apaf-1 is a key factor in the mitochondrial apoptotic pathway, including the induction of apoptosis by the p53 tumor suppressor (22, 23).”
BackgroundNagathihalli, N. S., Anilakumar, K. R., & Singh, O. V. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.015 · Cited by 60
“The allyl sulfur compounds formed by enzymatic activity when garlic is minced or crushed — such as allicin; water-soluble S-allylmercaptocysteine and S-allylcysteine; and oil-soluble diallyl disulfide (DADS), diallyl trisulfide and diallyl sulfide — probably account for the majority of these anticancer effects [6–9].”
BackgroundChromatin modification of Apaf-1 restricts the apoptotic pathway in mature neurons
Wright, K. M., Smith, M. I., Farrag, L., & Deshmukh, M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200708086 · Cited by 57
“…cient for transcriptional up-regulation of Apaf-1 and sensitivity to cytochrome c in mature neurons To determine how Apaf-1 is transcriptionally induced in mature neurons after etoposide treatment, we examined Apaf-1 transcription factors p53 and E2F1 (Fortin et al., 2001; Moroni et al., 2001).”
BackgroundSaha, A., Lu, J. L., Morizur, L., Upadhyay, S. K., Mahadesh Prasad, A. J., & Robertson, E. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002573 · Cited by 59
“Human wild-type p73 [45] and Apaf-1 [46] promoters linked to luciferase gene were obtained as kind gifts from Mirko Marabese (Istituto di Ricerche Farmacologiche ‘‘Mario Negri’’, Milan, Italy) and Kristian Helin (European Institute of Oncology, Milan, Italy), respectively.”
MethodSmall molecule regulators of Rb–E2F pathway as modulators of transcription
Singh, S., Johnson, J. L., & Chellappan, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.004 · Cited by 59
Senescence and Apoptosis: Architects of Mammalian Development
Wanner, E., Thoppil, H., & Riabowol, K. T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.620089 · Cited by 61
“Epigenetic modifications have frequently been implicated in both apoptosis and senescence (Moskalev et al., 2014).”
BackgroundXie, W., Jiang, P., Miao, L., Zhao, Y., Zhimin, Z., Qing, L., Zhu, W., & Wu, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl150 · Cited by 58
“ER-E2F1-expressing H1299 cell lines were derived from H1299 cells as described previously (23).”
BackgroundMethodInfluentialLi, J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg032 · Cited by 52
“Other p53 inducible genes that promote apoptosis include PERP [15], and APAF-1 [16].”
BackgroundModulation of p53 during bacterial infections
Siegl, C., & Rudel, T. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3537 · Cited by 57
Coupling of caspase‐9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell‐type‐specific
Ho, A. T. V., Li, Q. H., Hakem, R., Mak, T. W., & Zacksenhaus, E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600039 · Cited by 56
“To induce differentiation, myoblasts were allowed to reach confluency on gelatin-coated plates in GM and then switched to differentiation media (DM; HAM-F10, 2% horse serum and 10mg/ml insulin).”
MethodDeregulated E2f-2 Underlies Cell Cycle and Maturation Defects in Retinoblastoma Null Erythroblasts
Dirlam, A., Spike, B. T., & Macleod, K. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01118-07 · Cited by 56
“E2fs also regulate key mediators of programmed cell death such as Apaf-1 (25), caspases (28), and p73 (15), and more recently, E2fs have been shown to directly regulate genes involved in terminal differentiation (8, 26).”
BackgroundJiang, Z., & Zacksenhaus, E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200106084 · Cited by 55
“For example, deregulated E2F1 can induce the transcription of apoptosis protease-activating factor (Apaf)-1 (Moroni et al., 2001) and p14/19ARF, which binds and inactivates MDM2, a p53 inhibitor, thereby linking loss of Rb to p53-induced apoptosis (Sherr, 2000).”
BackgroundInfluentialRegulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation
Kumari, A., Iwasaki, T., Pyndiah, S., Cassimere, E. K., Palani, C. D., & Sakamuro, D. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.146 · Cited by 56
HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F–p73 pathway
Finzer, P., Krueger, A., Stöhr, M., Brenner, D., Soto, U., Kuntzen, C., Krammer, P. H., & Rösl, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207620 · Cited by 55
“However, similar to p14ARF, neither Apaf-1 (Moroni et al., 2001) nor Bcl-2 (Gomez-Manzano et al., 2001), all identified as potential E2F-1 target genes, were elevated upon NaB treatment using HeLa cell cDNAs as labeled probes for microarray analyses (data not shown).”
BackgroundInfluentialFOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function
Shats, I., Gatza, M. L., Liu, B., Angus, S. P., You, L., & Nevins, J. R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0453 · Cited by 54
“Helin (University of Copenhagen, Denmark) and described in (17).”
Punicalagin Regulates Apoptosis-Autophagy Switch via Modulation of Annexin A1 in Colorectal Cancer
Ganesan, T., Sinniah, A., Chik, Z., & Alshawsh, M. A. (2020) · Nutrients · doi:10.3390/nu12082430 · Cited by 54
“On the other hand, in intrinsic apoptosis, nuclear p53 activates pro-apoptotic proteins such as PIDD, NOXA, Bax and Bid [29], leading to increased MMP, cytochrome C release and activation of caspase 9 [30], whilst cytoplasmic p53 translocates to mitochondria to bind to anti-apoptotic proteins to prevent them from bind…”
BackgroundGenetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes
Tan, S. C., & Ankathil, R. (2015) · Tumor Biology · doi:10.1007/s13277-015-3868-2 · Cited by 54
“The role of p53 in the intrinsic apoptotic pathway is further supported by the observation that the tumor suppressor protein could also transactivate the gene encoding Apaf-1, which coactivates caspase-9 and leads to the initiation of the caspase cascade [97, 98].”
BackgroundMayank, A. K., Sharma, S., Nailwal, H., & Lal, S. K. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.360 · Cited by 54
“It is well established that E2F1-dependent apoptosis involves transcriptional activation of target genes such as APAF1 by E2F1 transcription factor, which further entails physical binding of E2F1 to target gene promoters.(35) In order to delineate mechanistic details of antiapoptotic effects of API5 on E2F1-triggered…”
BackgroundDenisenko, T. V., Pivnyuk, A. D., & Zhivotovsky, B. (2018) · Cancers · doi:10.3390/cancers10050148 · Cited by 54
Zanon, M., Piris, A., Bersani, I., Vegetti, C., Molla, A., Scarito, A., & Anichini, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1640 · Cited by 54
Mitogen requirement for cell cycle progression in the absence of pocket protein activity
Foijer, F., Wolthuis, R. M. F., Doodeman, V., Medema, R. H., & te Riele, H. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.021 · Cited by 53
“A simultaneous requirement for p53 and free E2F as was shown for Apaf-1 induction could explain this observation (Moroni et al., 2001).”
BackgroundMitochondrial functions and melatonin: a tour of the reproductive cancers
Chuffa, L. G. D. A., Seiva, F. R. F., Cucielo, M. S., Silveira, H. S., Reiter, R. J., & Lupi, L. A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2963-0 · Cited by 54
Molecular mechanisms of irradiation-induced apoptosis
Zhou, L. J., Yuan, R., & Serggio, L. (2003) · Frontiers in bioscience · doi:10.2741/927 · Cited by 53
“Apaf-1 is a direct transcriptional target of E2F and P53 and is implicated in E2F induced cell death (87,88).”
BackgroundKrippner‐Heidenreich, A., Walsemann, G., Beyrouthy, M. J., Speckgens, S., Kraft, R., Thole, H., Talanian, R. V., Hurt, M. M., & Lüscher, B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3704-3714.2005 · Cited by 53
“Among the transcription factors that have been implicated in the control of apoptosis are NF- B (25, 29), E2F factors (38, 39), the proto-oncoprotein c-Myc (47), and FOXO (10, 12, 58, 62).”
BackgroundAllelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome
Fujimoto, A., O'Day, S. J., Taback, B., Elashoff, D. A., & Hoon, D. S. �. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0957 · Cited by 53
Conserved RB functions in development and tumor suppression
Gordon, G. M., & Du, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1117-z · Cited by 53
“However cell death induced by E2F-1 is not universally dependent on TRP53 (Ginsberg, 2002), as it also has well-documented roles in the regulation of initiator (Moroni et al., 2001) and effector caspase function (Müller et al.”
BackgroundAryl Hydrocarbon Receptor Functions as a Potent Coactivator of E2F1-Dependent Trascription Activity
Watabe, Y., Nazuka, N., Tezuka, M., & Shimba, S. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.389 · Cited by 52
Apoptosis and chemo‐resistance in colorectal cancer
Prabhudesai, S. G., Rekhraj, S., Roberts, G., Darzi, A. W., & Ziprin, P. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20785 · Cited by 52
Le, H.-V., Minn, A. J., & Massagué, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504689200 · Cited by 51
Regulation of E2F1 by APC/CCdh1via K11 linkage-specific ubiquitin chain formation
Budhavarapu, V. N., White, E., Mahanic, C. S., Chen, L., Lin, F., & Lin, W.-C. (2012) · Cell Cycle · doi:10.4161/cc.20643 · Cited by 51
p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis
Amaral, J. D., Castro, R. E., Steer, C. J., & Rodrigues, C. M. P. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.09.005 · Cited by 51
Requirement for Aspartate-cleaved Bid in Apoptosis Signaling by DNA-damaging Anti-cancer Regimens
Werner, A. B., Tait, S. W. G., de Vries, E., Eldering, E., & Borst, J. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400268200 · Cited by 51
Fan, G., Ma, X., Wong, P., Rodrigues, C. M. P., & Steer, C. J. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000018803.11260.02 · Cited by 50
Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
Taneja, P., Zhu, S., Maglic, D., Fry, E. A., Kendig, R. D., & Inoue, K. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7516 · Cited by 50
Nath, N., Wang, S., Betts, V., Knudsen, E. S., & Chellappan, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206843 · Cited by 50
“In addition, other apoptosis-related proteins like Apaf1 are transcriptionally induced by E2F1 (Moroni et al., 2001), contributing to the apoptotic process.”
BackgroundHofer-Warbinek, R., Schmid, J. A., Mayer, H., Winsauer, G., Orel, L., Mueller, B., Wiesner, C., Binder, B. R., & de Martin, R. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401502 · Cited by 50
“Expression of APAF1 has been shown to be regulated by p53 and E2F-1.”
BackgroundTumor Suppressor p53 Mediates Apoptotic Cell Death Triggered by Cyclosporin A
Pyrzyńska, B., Serrano, M., Martínez‐A, C., & Kaminska, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104443200 · Cited by 50
Reddien, P. W., Andersen, E. C., Huang, M. C., & Horvitz, H. R. (2007) · Genetics · doi:10.1534/genetics.106.068148 · Cited by 50
Robinson, M., Jiang, P., Cui, J., Li, J., Wang, Y., Swaroop, M., Madore, S., Lawrence, T. S., & Sun, Y. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.437 · Cited by 49
Hauck, L., Stanley-Hasnain, S., Fung, A., Grothe, D., Rao, V., Mak, T. W., & Billia, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189861 · Cited by 48
Avivi, A., Ashur‐Fabian, O., Joel, A., Trakhtenbrot, L., Adamsky, K., Goldstein, I., Amariglio, N., Rechavi, G., & Nevo, E. (2006) · Oncogene · doi:10.1038/sj.onc.1210045 · Cited by 48
Solá, S., Castro, R. E., Kren, B. T., Steer, C. J., & Rodrigues, C. M. P. (2004) · Biochemistry · doi:10.1021/bi049781x · Cited by 48
Mahyar-Roemer, M., Fritzsche, C., Wagner, S., Laue, M. M., & Roemer, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207637 · Cited by 48
“…proteins Noxa and PUMA (Nakano and Vousden, 2001; Oda et al., 2000a; Yu et al., 2003), the apoptosome-constituent Apaf-1 (Fortin et al., 2001; Moroni et al., 2001; Robles et al., 2001), mitochondria-localized p53AIP (Oda et al., 2000b), plasma membrane-localized PERP (Attardi et al., 2000),…”
The Retinoblastoma Gene Family in Cell Cycle Regulation and Suppression of Tumorigenesis
Dannenberg, J.-H., & te Riele, H. P. J. (2006) · Results and Problems in Cell Differentiation · doi:10.1007/400_002 · Cited by 47
Jiang, J., Matranga, C. B., Cai, D. D., Latham, V. M., Zhang, X., Lowell, A. M., Martelli, F., & Shapiro, G. I. (2003) · PubMed · Cited by 47
Retinoblastoma Protein-mediated Apoptosis After γ-Irradiation
Bowen, C., Birrer, M. J., & Gelmann, E. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202000200 · Cited by 47
Nalam, R. L., Andreu‐Vieyra, C., Braun, R. E., Akiyama, H., & Matzuk, M. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0184 · Cited by 46
Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival
Phua, Y. L., Chu, J., Marrone, A. K., Bodnar, A. J., Sims‐Lucas, S., & Ho, J. (2015) · Physiological Reports · doi:10.14814/phy2.12537 · Cited by 46
“p53 functions in apoptosis as a direct transcriptional activator of proapoptotic genes including Bax, Trp53inp1, Puma, and Apaf-1 (Moroni et al. 2001; Nakano and Vousden 2001; Okamura et al. 2001; Chipuk et al. 2004).”
BackgroundMethodMahanic, C. S., Budhavarapu, V. N., Graves, J. D., Li, G., & Lin, W.-C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.659425 · Cited by 46
“Subsequently, E2F1 transcriptionally activates an apoptotic response in a p53-dependent pathway by activating p14ARF (12) and also in a p53independent manner by activating p73 (13), caspases (14), and Apaf-1 (15).”
BackgroundInfluentialActivation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2
Palmero, I., Murga, M., Zubiaga, A. M., & Serrano, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205371 · Cited by 46
“Apoptosis induced by E2F1 seems to involve several di erent pathways such as activation of p53 (Phillips et al., 1997; Kowalik et al., 1998; Pan et al., 1998), activation of the p53-related protein p73 (Irwin et al., 2000; Lissy et al., 2000), downregulation of the survival factor TRAF2 (Phillips et al., 1999), and in…”
BackgroundInfluentialAgger, K., Santoni‐Rugiu, E., Holmberg, C., Karlström, O. H., & Helin, K. (2004) · Oncogene · doi:10.1038/sj.onc.1208248 · Cited by 46
Self-citationInduction of apoptosis in cancer: new therapeutic opportunities
Ding, H., & Fisher, D. E. (2002) · Annals of Medicine · doi:10.1080/078538902321012405 · Cited by 47
“Moreover, E2F1 is able to transactivate a luciferase reporter gene under the control of the Apaf-1 promoter and mutations of two of the four consensus E2F-binding sites in the promoter region render the promoter insensitive to E2F1 expression.”
BackgroundInfluentialGlioblastoma Multiforme Stem Cells
Dimov, I., Tasic-Dimov, D., Conić, I., & Stefanović, V. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.42 · Cited by 45
“E2F-1, one of the major Rb targets, simultaneously activates apoptotic genes Apaf-1, P53, and Bax, as well as the genes required for entry into the S phase[68,69,70].”
BackgroundCastro, R. E., Solá, S., Ma, X., Ramalho, R. M., Kren, B. T., Steer, C. J., & Rodrigues, C. M. P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.026 · Cited by 45
“Apaf-1 was recently described as a direct transcriptional target of p53 [23].”
BackgroundTosi, G. M., Trimarchi, C., Macaluso, M., Sala, D. L., Ciccodicola, A., Lazzi, S., Massaro‐Giordano, M., Caporossi, A., Giordano, A., & Cinti, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208630 · Cited by 45
The Myelodysplastic Syndromes: A Matter of Life or Death
Parker, J. E., & Mufti, G. J. (2003) · Acta Haematologica · doi:10.1159/000074488 · Cited by 45
Zhao, Y., Ren, J., Wang, M., Zhang, S.-T., Liu, Y., Li, M., Cao, Y.-B., Zu, H.-Y., Chen, X., Wu, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320369110 · Cited by 44
“The p53 target apoptotic genes IGFBP3, Apoptotic protease activating factor 1 (Apaf1), BCL2-associated X protein (Bax), the Bcl-2 homology 3 (BH3)-only pro-apoptotic protein (Noxa), and P53 upregulated modulator of apoptosis (Puma) and the cell-cycle arrest genes p21 and the human homologue of mouse double minute 2 (H…”
BackgroundOgawa, T., Shiga, K., Hashimoto, S., Kobayashi, T., Horii, A., & Furukawa, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00995-1 · Cited by 44
Hughes, T. A., & Brady, H. J. M. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.014 · Cited by 44
Yun, T., Yu, K., Yang, S., Cui, Y., Wang, Z., Ren, H., Chen, S., Li, L., Liu, X., Fang, M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706341 · Cited by 42
Metadata
- Authors
- Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Rome Tor Vergata (IT)
- Nerviano Medical Sciences (IT)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2001-05-10
- Volume
- 3
- Issue
- 6
- Pages
- 552-558
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1497251274
- Cited by
- 593
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 22 · 2012: 22
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Apaf-1, E2F1, p53, retinoblastoma protein, transcriptional regulation, apoptosis, chemosensitivity, cancer cells, S phase entry
- MeSH terms
- Animals, DNA-Binding Proteins, Embryo, Mammalian, Humans, Promoter Regions, Genetic, Proteins, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Apoptotic Protease-Activating Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.